Hemodynamic Characteristics of Patients With SARS-CoV-2

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

March 13, 2020

Primary Completion Date

October 30, 2020

Study Completion Date

November 30, 2020

Conditions
CoronavirusSARS-CoV-2COVID-19Acute Respiratory Distress SyndromeShockAcute Circulatory FailureLeft Ventricular DysfunctionFluid Overload
Interventions
DEVICE

Transpulmonary thermodilution

Obtained by averaging the results of three thermodilution measurements. Each thermodilution is performed by injecting a bolus (15 mL) of cold saline (less than 10°C)

DEVICE

Echocardiography

Daily echocardiography evaluation

Trial Locations (1)

94270

Bicetre Hospital, Paris

All Listed Sponsors
lead

Bicetre Hospital

OTHER

NCT04337983 - Hemodynamic Characteristics of Patients With SARS-CoV-2 | Biotech Hunter | Biotech Hunter